Literature DB >> 33682337

Role of D-dimer and Fibrinogen in the Diagnosis of Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis.

Hong Xu1, Jin-Wei Xie1, Jing-Li Yang2, Ze-Yu Huang3, Fu-Xing Pei3.   

Abstract

The diagnostic potential of D-dimer and fibrinogen to detect periprosthetic joint infection (PJI) of the hip and knee is not well-understood. The aim of this study was to determine whether D-Dimer and fibrinogen can be used as effective biomarkers to screen PJI. A systematic review of the literature indexed in Web of Science, PubMed, Cochrane Library, Embase, and Google Scholar databases was performed. All studies using D-dimer levels in serum or plasma, or fibrinogen levels in plasma, for the diagnosis of PJI were included. Meta-analysis estimates, including sensitivity, specificity, diagnostic odds ratios (DOR), and the area under the summary receiver operating characteristic curve (AUSROC), were calculated using a random-effects model, and used to assess the diagnostic accuracy of these biomarkers. A total of nine studies were analyzed, and their quality was considered to be acceptable. D-dimer gave a limited diagnostic value if serum and plasma combined: sensitivity (0.77, 95% confidence interval [CI] [0.63 to 0.87]), specificity (0.67, 95% CI [0.54 to 0.78]), DOR (6.81, 95% CI [2.67 to 17.37]), and AUSROC (0.78, 95% CI [0.74 to 0.82]). Plasma D-dimer levels were associated with less satisfactory sensitivity (0.65, 95% CI 0.57 to 0.71), specificity (0.58, 95% CI 0.50 to 0.66), DOR (2.52, 95% CI 1.64 to 3.90), and AUSROC (0.65, 95% CI 0.61 to 0.69). Serum D-dimer levels showed higher corresponding values of 0.89 (95% CI 0.79 to 0.94), 0.76 (95% CI 0.55 to 0.89), 24.24 (95% CI 10.07 to 58.32), and 0.91 (95% CI 0.88 to 0.93). Plasma fibrinogen showed acceptable corresponding values of 0.79 (95% CI 0.70 to 0.85), 0.73 (95% CI 0.57 to 0.85), 10.14 (95% CI 6.16 to 16.70), and 0.83 (95% CI 0.79 to 0.86). Serum D-dimer may be an effective marker for the diagnosis of PJI in hip and knee arthroplasty patients, and it may show higher diagnostic potential than plasma fibrinogen. Plasma D-dimer may have limited diagnostic potential.
© 2021 The Authors. Orthopaedic Surgery published by Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  D-dimer; Fibrinogen; Meta-analysis; Periprosthetic joint infection; Plasma; Serum

Year:  2021        PMID: 33682337     DOI: 10.1111/os.12969

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  5 in total

1.  Limited value of coagulation parameters in diagnosing periprosthetic joint infection.

Authors:  Xia Chen; Jie Xie; Yanming Li; Zijuan Jian; Hongling Li; Qun Yan
Journal:  Int Orthop       Date:  2022-07-05       Impact factor: 3.479

2.  Plasma fibrinogen: a sensitive biomarker for the screening of periprosthetic joint infection in patients undergoing re-revision arthroplasty.

Authors:  Hong Xu; Li Liu; Jinwei Xie; Qiang Huang; Yahao Lai; Zongke Zhou
Journal:  BMC Musculoskelet Disord       Date:  2022-06-01       Impact factor: 2.562

3.  Plasma levels of D-dimer and fibrin degradation product are unreliable for diagnosing periprosthetic joint infection in patients undergoing re-revision arthroplasty.

Authors:  Hong Xu; Jinwei Xie; Duan Wang; Qiang Huang; Zeyu Huang; Zongke Zhou
Journal:  J Orthop Surg Res       Date:  2021-10-19       Impact factor: 2.359

4.  Diagnostic value of platelet indices in infected nonunion: a retrospective study.

Authors:  Zhen Wang; Hai-Jun Mao; Xu-Sheng Qiu; Yi-Xin Chen; Guang-Yue Xu
Journal:  J Orthop Surg Res       Date:  2022-04-04       Impact factor: 2.359

5.  Ability of plasma-based or serum-based assays of D-dimer and FDP for diagnosing periprosthetic joint infection: protocol for a prospective single-centre, parallel comparative study.

Authors:  Hong Xu; Jinwei Xie; Jing Zhou; Xing Wang; Duan Wang; Zeyu Huang; Zongke Zhou
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.